Mimedx (MDXG) Assets Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.10% |
| Dec 31, 2025 | 11.14% |
| Sep 30, 2025 | 8.38% |
| Jun 30, 2025 | 14.04% |
| Mar 31, 2025 | 11.22% |
| Dec 31, 2024 | 9.56% |
| Sep 30, 2024 | 6.35% |
| Jun 30, 2024 | 6.21% |
| Mar 31, 2024 | 15.59% |
| Dec 31, 2023 | 14.24% |
| Dec 31, 2022 | 7.17% |
| Sep 30, 2022 | -0.67% |
| Jun 30, 2022 | -3.34% |
| Mar 31, 2022 | -1.54% |
| Dec 31, 2021 | 9.89% |
| Sep 30, 2021 | -0.13% |
| Jun 30, 2021 | 1.11% |
| Mar 31, 2021 | 1.49% |
| Dec 31, 2020 | 8.25% |
| Sep 30, 2020 | 11.12% |
| Jun 30, 2020 | 5.80% |
| Mar 31, 2020 | 8.41% |
| Dec 31, 2019 | 8.88% |
| Sep 30, 2019 | 13.00% |
| Jun 30, 2019 | 14.64% |
| Mar 31, 2019 | 4.23% |
| Dec 31, 2018 | 7.72% |
| Dec 31, 2017 | 28.08% |
| Sep 30, 2017 | 39.74% |
| Jun 30, 2017 | 48.72% |
| Mar 31, 2017 | 47.65% |
| Dec 31, 2016 | 34.05% |
| Sep 30, 2016 | 50.47% |
| Jun 30, 2016 | 48.79% |
| Dec 31, 2015 | 79.21% |